Cutler Group LP Laboratory Corp Of America Holdings Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$213.86 - $277.87 $1.01 Million - $1.31 Million	-4,721 Reduced 78.68%	1,279 $299,000
Q1 2022 Apr 14, 2022	BUY	$259.82 - $298.18 $1.3 Million - $1.49 Million	5,000 Added 500.0%	6,000 $1.58 Million
Q3 2021 Oct 26, 2021	BUY	$274.82 - $308.34 $27,482 - $30,833	100 Added 11.11%	1,000 $281,000
Q2 2021 Jul 19, 2021	SELL	$251.87 - $278.14 $25,187 - $27,814	-100 Reduced 10.0%	900 $248,000
Q2 2019 Aug 09, 2019	SELL	$144.16 - $172.9 $241,612 - $289,780	-1,676 Reduced 62.63%	1,000 $172,000
Q1 2019 May 10, 2019	BUY	$123.7 - $156.3 $331,021 - $418,258	2,676 New	2,676 $409,000
Q4 2017 Jan 17, 2018	SELL	$147.99 - $163.95 $55,792 - $61,809	-377 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$149.47 - $160.56 $56,350 - $60,531	377	377 $56,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.